Takahiro Tsujikawa
Takahiro Tsujikawa
Otolaryngology-Head and Neck Surgery, Kyoto Prefectural University of Medicine
Verified email at koto.kpu-m.ac.jp
Cited by
Cited by
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ...
Science 359 (6371), 97-103, 2018
Bruton tyrosine kinase–dependent immune cell cross-talk drives pancreas cancer
AJ Gunderson, MM Kaneda, T Tsujikawa, AV Nguyen, NI Affara, B Ruffell, ...
Cancer discovery 6 (3), 270-285, 2016
Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis
T Tsujikawa, S Kumar, RN Borkar, V Azimi, G Thibault, YH Chang, ...
Cell reports 19 (1), 203-217, 2017
Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma
T Tsujikawa, T Yaguchi, G Ohmura, S Ohta, A Kobayashi, N Kawamura, ...
International journal of cancer 132 (12), 2755-2766, 2013
IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
RS Lane, J Femel, AP Breazeale, CP Loo, G Thibault, A Kaempf, M Mori, ...
Journal of Experimental Medicine 215 (12), 3057-3074, 2018
Aberrant myosin 1b expression promotes cell migration and lymph node metastasis of HNSCC
G Ohmura, T Tsujikawa, T Yaguchi, N Kawamura, S Mikami, J Sugiyama, ...
Molecular Cancer Research 13 (4), 721-731, 2015
Improvement of cancer immunotherapy by combining molecular targeted therapy
Y Kawakami, T Yaguchi, H Sumimoto, C Kudo-Saito, T Iwata-Kajihara, ...
Frontiers in oncology 3, 136, 2013
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
MT Saung, S Muth, D Ding, DL Thomas, AB Blair, T Tsujikawa, ...
Journal for immunotherapy of cancer 6 (1), 118, 2018
Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer
SM Reddy, A Reuben, S Barua, H Jiang, S Zhang, L Wang, ...
Cancer immunology research 7 (6), 1025-1035, 2019
Dissecting the stromal signaling and regulation of myeloid cells and memory effector T cells in pancreatic cancer
AB Blair, VM Kim, ST Muth, MT Saung, N Lokker, B Blouw, TD Armstrong, ...
Clinical Cancer Research 25 (17), 5351-5363, 2019
Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy
Y Kawakami, T Yaguchi, H Sumimoto, C Kudo‐Saito, N Tsukamoto, ...
Annals of the New York Academy of Sciences 1284 (1), 80-86, 2013
Trim32 deficiency enhances Th2 immunity and predisposes to features of atopic dermatitis
Y Liu, Z Wang, R De La Torre, A Barling, T Tsujikawa, N Hornick, J Hanifin, ...
Journal of Investigative Dermatology 137 (2), 359-366, 2017
Clinical response of live-attenuated, listeria monocytogenes expressing mesothelin (CRS-207) with chemotherapy in patients with malignant pleural mesothelioma
R Hassan, E Alley, H Kindler, S Antonia, T Jahan, S Honarmand, N Nair, ...
Clinical Cancer Research 25 (19), 5787-5798, 2019
Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status
C Means, DR Clayburgh, L Maloney, D Sauer, MH Taylor, ML Shindo, ...
Head & neck 41 (8), 2636-2646, 2019
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer
ND Pennock, HA Martinson, Q Guo, CB Betts, S Jindal, T Tsujikawa, ...
Journal for immunotherapy of cancer 6 (1), 1-23, 2018
Evaluation of cyclophosphamide/GVAX pancreas followed by Listeria-mesothelin (CRS-207) with or without nivolumab in patients with pancreatic cancer
T Tsujikawa, T Crocenzi, JN Durham, EA Sugar, AA Wu, B Onners, ...
Clinical Cancer Research, 2020
Using an in-house approach to computer-assisted design and computer-aided manufacturing reconstruction of the maxilla
T Numajiri, D Morita, H Nakamura, S Tsujiko, R Yamochi, Y Sowa, ...
Journal of Oral and Maxillofacial Surgery 76 (6), 1361-1369, 2018
Use of systemic low-dose unfractionated heparin in microvascular head and neck reconstruction: Influence in free-flap outcomes
T Numajiri, Y Sowa, K Nishino, A Arai, T Tsujikawa, K Ikebuchi, H Nakano, ...
Journal of Plastic Surgery and Hand Surgery 50 (3), 135-141, 2016
Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments
Y Kawakami, T Yaguchi, H Sumimoto, C Kudo-Saito, N Tsukamoto, ...
The Tumor Immunoenvironment, 307-323, 2013
High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers
G Banik, CB Betts, SM Liudahl, S Sivagnanam, R Kawashima, T Cotechini, ...
Methods in Enzymology 635, 1-20, 2020
The system can't perform the operation now. Try again later.
Articles 1–20